Lorlatinib for advanced ROS1+ non-small-cell lung cancer: results of the IFCT-1803 LORLATU study

  • Etude concernée: IFCT-1803
  • Auteurs / Authors: Girard N, Galland-Girodet S, Avrillon V, Besse B, Duruisseaux M, Cadranel J, Otto J, Prevost A, Roch B, Bennouna J, Bouledrak K, Coudurier M, Egenod T, Lamy R, Ricordel C, Moro-Sibilot D, Odier L, Tillon-Strozyk J, Zalcman G, Missy P, Westeel V, Baldacci S.
  • Journal / Conference: ESMO open
  • Année / Year: 2022
  • PMID: 35227966
  • Lien vers la publication: https://linkinghub.elsevier.com/retrieve/pii/S2059-7029(22)00039-4
  • PDF: PIIS2059702922000394.pdf